FAINARDI, Enrico
 Distribuzione geografica
Continente #
NA - Nord America 9.577
EU - Europa 2.641
AS - Asia 2.072
Continente sconosciuto - Info sul continente non disponibili 13
OC - Oceania 9
AF - Africa 8
SA - Sud America 3
Totale 14.323
Nazione #
US - Stati Uniti d'America 9.553
CN - Cina 1.030
UA - Ucraina 578
IT - Italia 561
SG - Singapore 543
DE - Germania 387
TR - Turchia 358
GB - Regno Unito 325
PL - Polonia 249
FI - Finlandia 165
SE - Svezia 157
ID - Indonesia 58
BE - Belgio 53
FR - Francia 48
CZ - Repubblica Ceca 31
HK - Hong Kong 30
AT - Austria 26
CA - Canada 23
VN - Vietnam 17
IR - Iran 16
NL - Olanda 9
AU - Australia 8
LT - Lituania 8
RU - Federazione Russa 8
A2 - ???statistics.table.value.countryCode.A2??? 7
EU - Europa 6
RO - Romania 6
IN - India 5
KR - Corea 5
IE - Irlanda 4
MA - Marocco 4
PT - Portogallo 4
BG - Bulgaria 3
BR - Brasile 3
CH - Svizzera 3
ES - Italia 3
IQ - Iraq 3
NG - Nigeria 3
SI - Slovenia 3
HR - Croazia 2
HU - Ungheria 2
JP - Giappone 2
SK - Slovacchia (Repubblica Slovacca) 2
EE - Estonia 1
GE - Georgia 1
HN - Honduras 1
LU - Lussemburgo 1
MD - Moldavia 1
MG - Madagascar 1
MK - Macedonia 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PK - Pakistan 1
TW - Taiwan 1
Totale 14.323
Città #
Woodbridge 1.338
Fairfield 1.093
Chandler 767
Houston 716
Jacksonville 673
Ashburn 609
Ann Arbor 561
Singapore 442
Wilmington 394
Seattle 371
Santa Clara 365
Cambridge 360
Warsaw 239
Izmir 234
Nanjing 218
Ferrara 187
Princeton 180
Beijing 160
Milan 139
Boardman 122
New York 116
Shanghai 108
San Diego 90
Addison 81
Dearborn 80
Los Angeles 69
Nanchang 66
Shenyang 63
Bremen 59
Jakarta 57
Brussels 53
Jiaxing 50
Hebei 46
Tianjin 43
Changsha 42
Norwalk 38
Falls Church 32
Hong Kong 30
Brno 29
San Mateo 28
Ningbo 26
Vienna 25
Helsinki 24
Jinan 24
Orange 23
Redwood City 23
Auburn Hills 21
London 21
Zhengzhou 19
Mountain View 18
Bologna 17
Kunming 17
Guangzhou 16
Dong Ket 15
Munich 15
Tappahannock 15
Toronto 15
Taizhou 14
Des Moines 13
Hefei 13
Rome 13
Verona 13
Washington 13
Leawood 12
Ardabil 10
Kraków 9
Frankfurt am Main 8
Indiana 8
Philadelphia 8
Augusta 7
Hangzhou 7
Kilburn 7
Ottawa 6
Redmond 6
Changchun 5
Falkenstein 5
Lanzhou 5
San Francisco 5
Burnley 4
Clifton 4
Haikou 4
Monmouth Junction 4
Parma 4
Simi Valley 4
Turin 4
Calderara Di Reno 3
Catania 3
Dublin 3
Espoo 3
Ferrara di Monte Baldo 3
Forest City 3
Fuzhou 3
Greifensee 3
Guardialfiera 3
Hounslow 3
Modena 3
Padova 3
Reggio Emilia 3
Sant'elena 3
Shaoxing 3
Totale 10.942
Nome #
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment 345
HLA-G Molecules in Autoimmune Diseases and Infections 164
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 156
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 156
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 148
Which elderly newly diagnosed glioblastoma patients can benefit from radiotherapy and temozolomide? A PERNO prospective study 142
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 140
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 139
Emerging topics and new perspectives on HLA-G 137
Matrix metalloproteinase 9 as a marker of disease activity in multiple sclerosis 133
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 132
Incidence of neuroepithelial primary brain tumors among adult population of Emilia-Romagna Region, Italy 130
Evaluation of acute perihematomal regional apparent diffusion coefficient abnormalities by diffusion-weighted imaging 130
Cerebrospinal fluid analysis and the determination of oligoclonal bands 129
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 129
Clinical and MRI disease activity in multiple sclerosis are associated with reciprocal fluctuations in serum and cerebrospinal fluid levels of soluble HLA class I molecules 128
Technical, Anatomical, and Functional Study after Removal of a Symptomatic Cavernous Angioma Located in Deep Wernicke's Territories with Cortico-Subcortical Awake Mapping. 127
Awake surgery in low-grade gliomas harboring eloquent areas: 3-year mean follow-up 127
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 127
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 123
Intrathecal Soluble HLA-E Correlates with Disease Activity in Patients with Multiple Sclerosis and may Cooperate with Soluble HLA-G in the Resolution of Neuroinflammation. 123
KIR2DL2 inhibitory pathway enhances Th17 cytokine secretion by NK cells in response to herpesvirus infection in multiple sclerosis patients 121
null 121
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 121
Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients 121
Serum IgG against Simian Virus 40 antigens are hampered by high levels of sHLA-G in patients affected by inflammatory neurological diseases, as multiple sclerosis 120
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 119
Survival prediction in high-grade gliomas using CT perfusion imaging 118
CT perfusion mapping of hemodynamic disturbances associated to acute spontaneous intracerebral hemorrhage 118
Leptin/adiponectin ratio predicts post-stroke neurological outcome 118
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 117
Spontaneous and idiopathic chronic spinal epidural hematoma: two case reports and review of the literature 116
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 113
Spinal anterior epidural hematoma in an elderly man with unrecognized lupic anticoagulant taking warfarin 112
Assessment of HIV-intrathecal humoral immune response in AIDS-related neurological disorders 111
null 110
Study of Soluble HLA-G in Congenital Human Cytomegalovirus Infection 110
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 109
null 109
Alterazioni liquorali nella sindrome di Guillain-Barrè: Utilità nella diagnosi e nel monitoraggio della malattia. 108
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 105
Presence of detectable levels of soluble HLA-G molecules in CSF of relapsing-remitting multiple sclerosis: relationship with CSF soluble HLA-I and IL-10 concentrations and MRI findings 105
null 104
null 102
New insights into HLA-G and inflammatory diseases 102
Recent advances in our understanding of HLA-G biology: Lessons from a wide spectrum of human diseases 102
Some basic aspects of HLA-G biology. 101
Intrathecal production of Chlamydia pneumoniae-specific high-affinity antibodies is significantly associated to a subset of multiple sclerosis patients with progressive forms 101
The incidence of Guillain-Barrè syndrome in Ferrara, Italy: is the disease really increasing? 99
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 98
null 97
null 97
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 97
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 97
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 97
The role of stage-specific oligonucleotide primers in providing effective laboratory support for the molecular diagnosis of reactivated Toxoplasma gondii encephalitis in patients with AIDS 97
null 96
Exogenous gangliosides and Guillain-Barre syndrome. An observational study in the Local Health District of Ferrara, Italy 96
Detection of JC virus DNA in cerebrospinal fluid from multiple sclerosis patients 96
Temporal changes in CT perfusion values before and after cranioplasty in patients without symptoms related to external decompression: A pilot study 95
Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. 95
Neurofilament ELISA validation 94
Clinical and MRI activity are associated to elevated cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-9 in multiple sclerosis patients 93
Hyperfusion Syndrome Secondary to Carotid Endovascular Rivascularization: a case report 93
A new developed culture method efficiently supports the growth of Chamydia pneumoniae in PBMC and CSF samples from patients with Multiple Sclerosis 93
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 92
A Further Evidence Of Pathogenic Role Of Chlamydia Pneumoniae In Multiple Sclerosis 92
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 92
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 90
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 90
null 90
Antigeni solubili di classe I classici e non classici (sHLA G) nei fluidi cerebrospinali della sclerosi multipla 88
null 88
null 87
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 87
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 85
null 84
Matrix metalloproteinases (MMP): determination of different forms by different techniques may require different preanalytical strategies 84
null 84
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 84
Hyperperfusion syndrome secondary to carotid endovascular rivascularization: a case report 84
Le catene leggere libere liquorale sclerosi multipla 83
null 83
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 83
INTRATHECAL PRODUCTION OF ACTIVE FORM OF MATRIX METALLOPROTEINASES-9 IN PATIENTS WITH MULTIPLE SCLEROSIS: PRELIMINARY RESULTS” 82
Impaired Cerebral Venous Haemodynamics In Multiple Sclerosis Patients 81
25 hydroxyvitamin D in cerebrospinal fluid from patients with multiple sclerosis during relapse and remission 80
Detection of Parachlamydialike organisms in patients with multiple sclerosis. 78
Inverse association between CSF levels of solubile HLA-G and Fas molecules in MS patients with no evidence of MRI disease activity. 78
Cerebrospinal fluid (CSF) Protein Immunoglobulin and cellular abnormalities in Acquired Immune Deficiency Syndrome (AIDS) 78
Therapeutic plasma exchange for worsening relapsing remitting multiple sclerosis. A case report 77
Analysis of MMP-9 in CSF and sera of patients with neurological diseases 76
Cerebrospinal fluid oligoclonal free light chain profiles in AIDS 75
Cerebrospinal fluid and serum levels and intrathecal production of active matrix metalloproteinase-9 are elevated in in multiple sclerosis patients with disease activity 75
null 75
Significance of anti-Chlamydophila pneumoniae IgA and IgG determination in patients with acute and post-acute ischaemic stroke 74
Influence of different strategies of volume replacement on the activity of matrix metalloproteinases: an in vitro and in vivo study 73
The role of [123I]-FP-CIT SPECT in the diagnosis and clinical menagement of Parkinson's disease 73
Chlamydia pneumonia-specific CFS-restricted oligoclonal IgG bands are associated to a subset of patients with prosessive forms of multiple sclerosis. 71
Under the microscope: Focusing on Chlamydia pneumoniae infection and Multiple Sclerosis 70
Totale 10.575
Categoria #
all - tutte 72.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 592
Totale 73.038


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.717 0 0 0 0 172 345 260 282 207 296 102 53
2020/20211.843 153 131 72 195 78 178 64 221 70 270 283 128
2021/20221.609 84 183 96 51 54 73 76 94 52 143 133 570
2022/20231.809 182 154 69 247 279 237 122 168 208 7 92 44
2023/20241.050 95 107 52 28 110 198 35 89 31 29 24 252
2024/20251.192 103 92 310 158 529 0 0 0 0 0 0 0
Totale 14.612